Literature DB >> 3086506

Secretion of neuron-specific enolase, prolactin, growth hormone, luteinising hormone and follicle stimulating hormone by "functionless" and endocrine-active pituitary tumours in vitro.

N F Lawton, A J Evans, J D Pickard, S Perry, B Davies.   

Abstract

Secretion of the neuroendocrine marker neuron-specific enolase by 24 pituitary tumours was measured in maintenance tissue culture. Eleven endocrine-active and 13 "functionless" tumours were defined by measurement of prolactin, growth hormone, luteinising hormone (LH) and follicle stimulating hormone (FSH) secretion rates in vitro and the corresponding plasma hormone levels. Measurement of prolactin secretion provided a clear distinction between true prolactinomas and "functionless" tumours causing hyperprolactinaemia by stalk compression (pseudoprolactinomas). A previous report of LH and/or FSH secretion by the majority of "functionless" tumours was confirmed, but plasma levels of LH and FSH were usually normal. It is argued that LH and FSH are not the major hormones secreted by "functionless" tumours. A high production rate of neuron-specific enolase appears to be characteristic of the cell type from which most "functionless" tumours derive.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3086506      PMCID: PMC1028812          DOI: 10.1136/jnnp.49.5.574

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

1.  Measurement of neuron-specific (NSE) and non-neuronal (NNE) isoenzymes of enolase in rat, monkey and human nervous tissue.

Authors:  P J Marangos; D Schmechel; A M Parma; R L Clark; F K Goodwin
Journal:  J Neurochem       Date:  1979-07       Impact factor: 5.372

2.  Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells.

Authors:  D Schmechel; P J Marangos; M Brightman
Journal:  Nature       Date:  1978 Dec 21-28       Impact factor: 49.962

3.  An FSH-producing pituitary tumor in a patient with hypogonadism.

Authors:  P D Woolf; E A Schenk
Journal:  J Clin Endocrinol Metab       Date:  1974-04       Impact factor: 5.958

4.  Secretion of alpha subunit of glycoprotein hormones by pituitary adenomas.

Authors:  I A Kourides; B D Weintraub; S W Rosen; E C Ridgway; B Kliman; F Maloof
Journal:  J Clin Endocrinol Metab       Date:  1976-07       Impact factor: 5.958

5.  Enolase isoenzymes in the cerebrospinal fluid of patients with diseases of the nervous system.

Authors:  J A Royds; G A Davies-Jones; N A Lewtas; W R Timperley; C B Taylor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-11       Impact factor: 10.154

6.  Null cell adenoma of the human pituitary.

Authors:  K Kovacs; E Horvath; N Ryan; C Ezrin
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

7.  Galactorrhea, oligo/amenorrhea, and hyperprolactinemia in patients with craniopharyngiomas.

Authors:  L P Kapcala; M E Molitch; K D Post; B J Biller; R J Prager; I M Jackson; S Reichlin
Journal:  J Clin Endocrinol Metab       Date:  1980-10       Impact factor: 5.958

8.  Glycoprotein hormone alpha subunit secretion by pituitary adenomas: influence of external irradiation.

Authors:  I A Macfarlane; C G Beardwell; S M Shalet; P J Darbyshire; E Hayward; M L Sutton
Journal:  Clin Endocrinol (Oxf)       Date:  1980-09       Impact factor: 3.478

9.  Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.

Authors:  D L Barrow; G T Tindall; K Kovacs; M O Thorner; E Horvath; J C Hoffman
Journal:  J Neurosurg       Date:  1984-01       Impact factor: 5.115

10.  Brain endolases as specific markers of neuronal and glial cells.

Authors:  D Schmechel; P J Marangos; A P Zis; M Brightman; F K Goodwin
Journal:  Science       Date:  1978-01-20       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.